Patents by Inventor Marvin Barry Cohen

Marvin Barry Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220211697
    Abstract: Described herein are methods for using compounds that activate pyruvate kinase.
    Type: Application
    Filed: December 15, 2021
    Publication date: July 7, 2022
    Inventors: Samuel V. Agresta, Yue Chen, Marvin Barry Cohen, Lenny Dang, Charles Kung, Elizabeth A. Merica, Bruce Alan Silver, Hua Yang
  • Patent number: RE40387
    Abstract: The invention relates to methods of increasing the bioavailability of orally administered epothilones. Epothilones administered by the methods of the invention are sufficiently bioavailable to have a pharmacological effect. The invention further relates to pharmaceutical compositions, pharmaceutical dosage forms, and kits for use in the methods of the invention.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: June 17, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Rebanta Bandyopadhyay, Timothy M. Malloy, Andrea Panaggio, Krishnaswamy Srinivas Raghavan, Sailesh Amilal Varia, Marvin Barry Cohen